Improved glucose control: Targeting GLP-1 and GIP receptors, retatrutide demonstrates promising results in improving insulin sensitivity and glucose regulation
Use the map for directions, or contact our team directly to schedule your visit
The FDA has not evaluated the safety or effectiveness of compounded BPC-157 for these indications
Product Code: GV-BACWAT-20ML Preserved aqueous laboratory solution containing 0.9% benzyl alcohol Appearance: Colourless liquid Clarity: Clear, no visible foreign matter Supplied in sealed 20mL laboratory vial Suitable for laboratory training, procedural simulation, and educational demonstration environments Recommended disposal within 28 days after opening when used in controlled environments Not for human or veterinary therapeutic use This preserved aqueous laboratory solution is supplied in a 20mL vial and is suitable for training, procedural simulation, and educational laboratory environments
This was a medical article that came across our desk: People are Overdosing on Semaglutide Drugs like Ozempic and Wegovy. Given that we do a lot of semaglutide and tirzepatide, as we think GLP-1 agonists are great for many patients, we wanted to see what it said
